Jacobs Levy Equity Management
MCRB icon

Jacobs Levy Equity Management’s Seres Therapeutics MCRB Stock Holding History

Jacobs Levy Equity Management’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,210
Closed -$454K – 1007
2023
Q4 		$454K Buy
+16,210
New +$426K ﹤0.01% 845
2022
Q3 		– Sell
-23,756
Closed -$1.63M – 1104
2022
Q2 		$1.63M Sell
23,756
-23,251
-49% -$2M 0.01% 649
2022
Q1 		$6.69M Sell
47,007
-17,508
-27% -$2.69M 0.05% 365
2021
Q4 		$10.7M Buy
+64,515
New +$10.3M 0.07% 287
2020
Q4 		– Sell
-1,141
Closed -$646K – 1062
2020
Q3 		$646K Sell
1,141
-10,624
-90% -$3.53M 0.01% 741
2020
Q2 		$1.12M Buy
11,765
+1,146
+11% +$101K 0.01% 649
2020
Q1 		$758K Sell
10,619
-6,051
-36% -$406K 0.01% 687
2019
Q4 		$1.15M Buy
16,670
+8,813
+112% +$654K 0.01% 668
2019
Q3 		$630K Buy
7,857
+4,243
+117% +$280K 0.01% 688
2019
Q2 		$233K Sell
3,614
-6,205
-63% -$589K ﹤0.01% 853
2019
Q1 		$1.35M Buy
9,819
+2,815
+40% +$343K 0.02% 596
2018
Q4 		$633K Buy
7,004
+490
+8% +$68.6K 0.01% 697
2018
Q3 		$989K Sell
6,514
-460
-7% -$74.4K 0.01% 650
2018
Q2 		$1.2M Buy
6,974
+2,540
+57% +$415K 0.02% 618
2018
Q1 		$651K Sell
4,434
-27
-0.6% -$5.18K 0.01% 730
2017
Q4 		$905K Buy
+4,461
New +$917K 0.02% 634

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Jacobs Levy Equity Management's MCRB Position: Q1 2024 in Review

Jacobs Levy Equity Management sold out of Seres Therapeutics (MCRB) in Q1 2024, closing a stake of 16,210 shares — an estimated $454K sold.

Jacobs Levy Equity Management first reported a position in MCRB in Q4 2017 and held it in 16 quarters. The position peaked at $10.7M in Q4 2021. 99 funds tracked by Wall St. Rank hold MCRB as of Q1 2024.

  • Jacobs Levy Equity Management reported no remaining Seres Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 16,210 Seres Therapeutics shares in Q1 2024, an estimated $454K.
  • Jacobs Levy Equity Management first reported a position in Seres Therapeutics in Q4 2017 and held it in 16 quarters.
  • Jacobs Levy Equity Management's Seres Therapeutics position peaked at $10.7M in Q4 2021.
  • 99 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2024, filed 15 May 2024.